ACS Central ScienceNeurosciencePeer-reviewed journal article
Discovery of volatile biomarkers of Parkinsons disease from sebum
Drupad K. TrivediiD, Eleanor SinclairiD, Yun Xu AiD, Depanjan SarkariD, Caitlin Walton‐DoyleiD, Camilla Liscio, Phine Banks, Joy MilneiD, Monty SilverdaleiD, Tilo KunathiD, Royston GoodacreiD, Perdita E. BarraniD
Abstract
Parkinsons disease (PD) is a progressive, neurodegenerative disease that presents with significant motor symptoms, for which there is no diagnostic test (1-3). We have serendipitously identified a hyperosmic individual, a Super Smeller that can detect PD by odor alone, and our early pilot studies have indicated that the odor was present in the sebum from the skin of PD subjects(4). Here, we have employed an unbiased approach to investigate the volatile metabolites of sebum samples obtained non-invasively from the upper back of 64 participants in total (21 controls and 43 PD subjects). Our results, validated by an independent cohort, identified a distinct volatiles-associated signature of PD, including altered levels of perillic aldehyde and eicosane, the smell of which was then described as being highly similar to the scent of PD by our Super Smeller.\n\n1 sentence summaryMetabolomics identifies volatile odorous compounds from patient sebum that associate with the smell of Parkinsons.
- organism: human
- assay: metabolomics
- research focus: differential expression
- approach: statistical model
- Citations
- 169
- FWCI
- 5.82
- Field percentile
- top 3%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Classification of Parkinson's Disease and Delineating Progression Markers from the Sebum Volatilome
Caitlin Walton‐Doyle, Beatrice Heim, … Drupad K. Trivedi·bioRxiv·Mar 1, 2023
- From small to tall: breed-varied household pet dogs can be trained to detect Parkinson's Disease
L. Holt, S. V. Johnston·bioRxiv·Jan 29, 2024
- Levodopa and dopamine dynamics in Parkinson’s disease metabolomics
Rachel C. Branco, William Ellsworth, … Gary Wright Miller·bioRxiv·May 22, 2018
- Personalized Metabolite Biomarker Predictions Reveal Heterogeneous Characteristics of Parkinson's Disease
Ecehan Abdi̇k, Tunahan Çakır·npj Parkinson s DiseasePeer-reviewed·Apr 21, 2026
- Early diagnosis of Parkinson's disease: A cross-species biomarker
D. Mallet, T. Dufourd, … S. Boulet·bioRxiv·Oct 4, 2021
- Identification and Validation of N-Acetylputrescine in Combination With Non-Canonical Clinical Features As a Parkinsons Disease Biomarker Panel
Kuan‐Wei Peng, Allison Klotz, … Michael A. Kiebish·Scientific ReportsPeer-reviewed·May 1, 2024